Proficio Capital Partners LLC Intercept Pharmaceuticals, Inc. Transaction History

Proficio Capital Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $4,460 - $6,114	-76 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$77.77 - $120.68 $933 - $1,448	-12 Reduced 13.64%	76 $6,000
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $3,581 - $4,706	39 Added 79.59%	88 $10,000
Q2 2018 Aug 10, 2018	BUY	$60.0 - $85.67 $600 - $856	10 Added 25.64%	49 $4,000
Q1 2018 May 14, 2018	SELL	$52.72 - $67.25 $1,107 - $1,412	-21 Reduced 35.0%	39 $2,000

Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $873 - $1,091	15 Added 33.33%	60 $4,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $2,565 - $5,343	45	45 $3,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.